- 355 facilities across 20 states after recent acquisitions
- 7,600+ new beds added, including 4,049 in Florida
- 84% of PACS facilities rated 4- or 5-stars by CMS (mid-2026)
Experts would likely conclude that PACS Group's aggressive expansion strategy, while financially innovative and operationally ambitious, faces significant challenges in maintaining care quality and regulatory compliance during rapid integration.
PACS Group’s Power Play: Inside the Strategy Reshaping U.S. Skilled Nursing
SALT LAKE CITY, UT – September 01, 2026 – On the surface, the announcement from PACS Group, Inc. was a straightforward declaration of corporate growth. The Salt Lake City-based holding company revealed definitive agreements to take over operations of 32 skilled nursing facilities in Florida, along with the near-complete acquisition of another 31 facilities from Eduro Healthcare. In a single move, PACS vaulted its portfolio to 355 facilities across 20 states, solidifying its status as a titan in the post-acute care landscape.
But beyond the staggering numbers—over 7,600 new beds and entry into four new states—lies a more complex story. This isn't just about getting bigger. It's a calculated, aggressive strategy that could redefine the economics and delivery of skilled nursing care in America. PACS Group's expansion is a case study in modern healthcare consolidation, fueled by a sophisticated financial model and a bold operational promise that will now be put to the test on its biggest stage yet.
A National Footprint, A Florida Focus
The scale of PACS Group’s ambition is now undeniable. The acquisition of 32 facilities in Florida, with their 4,049 licensed beds, is not a tentative first step but a cannonball into one of the nation's most critical and fastest-growing healthcare markets. Florida’s aging demographic represents a powerful tailwind for post-acute care providers, a fact not lost on PACS leadership.
“Entering a new state and expanding into a dynamic new market is an exciting opportunity for PACS,” said Jason Murray, the company's Chairman and CEO, in the official announcement. “Florida represents an attractive, high-growth market that aligns with our long-term strategy.”
This move creates an instant, statewide network for the company, transforming it from a newcomer into a premier provider across the Sunshine State's most vital healthcare corridors. It’s a classic consolidation play in a skilled nursing market that, despite the presence of large players, remains highly fragmented. By acquiring a massive cluster of facilities at once, PACS gains immediate economies of scale, negotiating power with suppliers and insurers, and a significant market share that would have taken years to build organically.
The simultaneous closing of the Eduro Healthcare deal, which extends the company's reach into New Mexico, North Dakota, and South Dakota, underscores a national strategy. PACS is methodically planting its flag in regions with demographic demand, aiming to become a dominant force not just in the South, but across the country.
The ‘Locally Led’ Promise Meets Reality
With rapid expansion comes the critical question of quality. How does a massive, centrally-managed holding company ensure high standards of care across hundreds of unique communities? PACS Group’s answer is its "locally led, centrally supported model." The philosophy, as articulated by President and COO Josh Jergensen, is to empower local facility leaders while the corporate parent handles the burdensome administrative tasks—accounting, HR, IT, and legal support.
“Our model is built on the belief that healthcare is local and that great outcomes start with strong, empowered leaders,” Murray stated.
There is data to support the potential efficacy of this approach. As of mid-2026, nearly 84% of PACS's rated facilities held a 4- or 5-star quality rating from the Centers for Medicare & Medicaid Services (CMS), a figure that suggests a strong operational track record. The challenge will be replicating this success across dozens of new facilities, each with its own culture, staff, and community relationships.
The integration of the Florida facilities will be a crucial test. Industry experts note that while a centralized support system can create efficiencies, it can also clash with local practices. Furthermore, the skilled nursing industry is grappling with a nationwide staffing crisis. Attracting and retaining qualified nurses and aides in a competitive market like Florida will be one of the most significant hurdles for the new operator. Success will depend on whether the "locally led" model truly empowers facility managers to address local staffing needs and morale, or if it becomes a top-down mandate.
The REIT-Fueled Growth Engine
Underpinning PACS Group's blistering expansion is a shrewd financial strategy heavily reliant on Real Estate Investment Trusts (REITs). The 32 Florida facilities, for instance, are not being purchased outright but leased from Omega Healthcare Investors (OHI), a major healthcare REIT and an existing PACS partner.
This "asset-light" model is key to understanding the company's growth trajectory. By leasing rather than buying the physical buildings, PACS avoids tying up billions in capital. This frees up cash to invest in operations, technology, and, crucially, more acquisitions. It’s a capital-efficient engine for expansion, allowing the company to grow its operational footprint at a speed that would be impossible through traditional real estate ownership. The REIT partner gets a reliable, long-term tenant, while the operator—PACS—gets to focus on what it does best: managing patient care.
However, this strategy is not without risk. The long-term lease agreements create substantial fixed costs. An economic downturn, a shift in Medicare reimbursement rates, or a dip in occupancy could put pressure on profitability. The health of PACS is now intrinsically linked to the health of its REIT partners, creating a complex web of financial interdependencies. For now, with occupancy in its mature facilities hovering above 93%, the model appears robust.
Growth Amidst Scrutiny
Investors have rewarded PACS Group’s aggressive strategy, with its stock price showing remarkable gains over the past year. The company’s second-quarter earnings for 2026 were strong, prompting it to raise its full-year revenue and profit guidance. This financial performance seems to validate the growth narrative.
Yet, a closer look reveals a more complex picture. The company is currently navigating ongoing government investigations and has disclosed "material weaknesses" in its internal financial controls, issues management hopes to resolve by the end of the year. These challenges, stemming in part from past allegations over billing practices, cast a shadow and suggest that the company's rapid growth may have outpaced its internal processes.
Furthermore, public filings have shown significant insider selling by top executives in recent months, a data point that often gives investors pause. While there can be many reasons for executives to sell shares, the scale of the sales against the backdrop of internal control issues and regulatory scrutiny adds a layer of caution to the otherwise bullish growth story. It highlights the central tension for PACS Group: balancing explosive expansion with the critical need for robust, transparent, and compliant operations.
The acquisitions in Florida and beyond mark a pivotal moment. PACS Group is making a bold statement about its vision for the future of post-acute care—one defined by scale, operational efficiency, and a decentralized management philosophy. The coming months will reveal if this high-stakes strategy will build a more resilient and effective elder care system or if the pressures of rapid integration and underlying operational challenges will prove too great.
Topics & Related
M&A
Occupancy Rate
📝 This article is still being updated
Are you a relevant expert who could contribute your opinion or insights to this article? We'd love to hear from you. We will give you full credit for your contribution.
Contribute Your Expertise →